346 related articles for article (PubMed ID: 25081299)
1. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.
Yang D; Hanna DL; Usher J; LoCoco J; Chaudhari P; Lenz HJ; Setiawan VW; El-Khoueiry A
Cancer; 2014 Dec; 120(23):3707-16. PubMed ID: 25081299
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.
Chen C; Jiang Y; Yang F; Cai Q; Liu J; Wu Y; Lin H
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):640-648. PubMed ID: 33051117
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma.
Aparo S; Goel S; Lin D; Ohri N; Schwartz JM; Lo Y; Kaubisch A
Cancer; 2014 Dec; 120(23):3683-90. PubMed ID: 25081065
[TBL] [Abstract][Full Text] [Related]
4. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
5. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
6. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
8. Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma.
Zhang Y; Brodin NP; Ohri N; Thibaud S; Kaubisch A; Kinkhabwala M; Garg M; Guha C; Kabarriti R
Hepatol Int; 2019 Sep; 13(5):609-617. PubMed ID: 31372942
[TBL] [Abstract][Full Text] [Related]
9. Association of nativity with survival among adults with hepatocellular carcinoma.
Zhou K; Song Z; Rostomian N; Dodge JL; Stern MC; Setiawan VW; Terrault NA; Cockburn MG; Liu L
J Natl Cancer Inst; 2023 Jul; 115(7):861-869. PubMed ID: 37160726
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
[TBL] [Abstract][Full Text] [Related]
11. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
[TBL] [Abstract][Full Text] [Related]
13. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
14. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
17. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.
Ailawadhi S; Advani P; Yang D; Ghosh R; Swaika A; Roy V; Foran J; Colon-Otero G; Chanan-Khan A
Cancer; 2016 Feb; 122(4):618-25. PubMed ID: 26565660
[TBL] [Abstract][Full Text] [Related]
18. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
Costa LJ; Brill IK; Brown EE
Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and racial/ethnic differences in hepatocellular carcinoma risk: the multiethnic cohort.
Setiawan VW; Hernandez BY; Lu SC; Stram DO; Wilkens LR; Le Marchand L; Henderson BE
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25326644
[TBL] [Abstract][Full Text] [Related]
20. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]